Dosing Gets Further Precision With New Drug Delivery Tech
Throughout the last four to five years, there has been a persistent problem, which was noted by Willus Fisher, a doctoral candidate at UC...
Understanding And Addressing Drug Shortage Issues In The EU
The European Commission has released findings from a pilot study aimed at understanding the difficulties in ensuring secure drug supply chains. According to the...
The Role of Partnerships In Managing Clinical Trial Costs
Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success.
At the 13th Annual Clinical...
Insights Into $3.72B Clinical Trial Supplies Market By 2028
The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a...
New FDA Guidance To Enhance Diversity In Clinical Trials
The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors...
Great Point Partners Acquires Lyocontract – A German CDMO
On a mission so as to debut the life sciences companies on an international stage, Great Point Partners, the healthcare investment firm, is making...
Transforming In 2024 & Beyond – Prefilled Syringes Market
Prefilled syringes have gone on to make up a decent portion in terms of injectable packaging segment in the past 10 years. As per...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...